NewsMore 
August 3, 2007; CHINDEX INTERNATIONAL, INC. SIGNS CONTRACT FOR FIRST EXIM-SPONSORED MEDICAL EQUIPMENT SALE IN CHINA UNDER NEW EXIM-MOF FRAMEWORK
July 26, 2007; CHINDEX INTERNATIONAL ANNOUNCES EXCLUSIVE SUPPLY AGREEMENT WITH CHINAS LARGEST HOSPITAL SYSTEM FOR SIEMENS ULTRASOUND PRODUCTS
     
   
  Home » News » Press Release
 
CHINDEX INTERNATIONAL, INC. ANNOUNCES TWO-FOR-ONE STOCK SPLIT

BETHESDA, MD (August 6, 2003) - Chindex International, Inc. (NASDAQ: CHDX - News) (the “Company”) today announced that its Board of Directors has unanimously approved a two-for-one split of the Company’s Common Stock, including its Class B Common Stock. Stockholders of record as of the close of business on August 18, 2003 will receive one additional share of Common Stock for each share owned on that date in the form of a stock dividend. Certificates representing the additional shares of Common Stock will be distributed on or about September 2, 2003.

The effect of the stock split will be to increase the number of outstanding shares of the Common Stock, excluding the Class B Common Stock, from approximately 740,000 shares to approximately 1.5 million shares and to increase the number of outstanding shares of the Class B Common Stock from 193,750 shares to 387,500 shares.

Roberta Lipson, Chairperson of the Board of Directors and Chief Executive Officer, stated, “This stock split reflects both the recent strong performance of our stock and our confidence in the Company’s prospects for further growth and is intended to improve market liquidity for our stockholders and to lead to wider ownership.”

The Company is a leading American company in healthcare in the Chinese marketplace including Hong Kong. It provides representative and distribution services to a number of major multinational companies including Siemens AG (diagnostic color ultrasound scanners under the Acuson and Siemens brand names), Becton-Dickinson (including vascular access, infusion and critical care systems), Johnson & Johnson (clinical chemistry analyzers), and Guidant (interventional cardiology products including stents, balloon catheters, and guide wires). It also provides healthcare services through the operations of its private hospital corporation in China. With twenty years of experience, more than 600 employees, and operations in the United States, China and Hong Kong, the Company’s strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to China's professional communities.

Further company information may be found at the Company’s websites, www.chindex.com and www.unitedfamilyhospitals.com.

The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties. These statements are based on management's beliefs and assumptions, and on information currently available to management. These statements involve certain known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward looking statements.

These factors include, among others, the Company's ability to effect the stock split; changes in the market price of Common Stock and other market conditions; requirements of Nasdaq; and any uncertainties relating to business, economic and political conditions in market in which the Company operates. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


 


Copyright © 2002 Chindex International, Inc. All Rights Reserved